Immunome Stock (NASDAQ: IMNM) stock price, news, charts, stock research, profile.
Open | $14.760 |
Close | $14.270 |
Volume / Avg. | 555.483K / 790.202K |
Day Range | 14.200 - 14.920 |
52 Wk Range | 4.440 - 30.958 |
Market Cap | $865.567M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 23 |
Short Interest | 5.57% |
Days to Cover | 5.75 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Immunome (NASDAQ: IMNM) through any online brokerage.
Other companies in Immunome’s space includes: Macrogenics (NASDAQ:MGNX), ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB), Zentalis Pharma (NASDAQ:ZNTL) and Centessa Pharmaceuticals (NASDAQ:CNTA).
The latest price target for Immunome (NASDAQ: IMNM) was reported by Guggenheim on Monday, April 15, 2024. The analyst firm set a price target for 35.00 expecting IMNM to rise to within 12 months (a possible 141.38% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Immunome (NASDAQ: IMNM) is $14.5 last updated Today at April 24, 2024 at 4:04 PM EDT.
There are no upcoming dividends for Immunome.
Immunome’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Immunome.
Immunome is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.